The pharmaceutical industry stands at the cusp of a transformative era, where the integration of sustainability within the supply chain is not just a trend, but a necessity. The 2024 ISPE Annual Meeting &...
The pharmaceutical industry stands at the cusp of a transformative era, where the integration of sustainability within the supply chain is not just a trend, but a necessity. The 2024 ISPE Annual Meeting &...
The explosive growth of advanced therapy medicinal products (ATMPs), particularly cellular therapeutics, has driven steady investment in facilities capable of manufacturing these therapeutics at scale . Meanwhile, the industry is collectively moving to adapt to European Union Annex 1 standards, which places a more stringent emphasis on contamination control.1
The global pharmaceutical industry has faced unprecedented challenges in recent years, with the COVID-19 pandemic serving as a wake-up call for the vulnerabilities within the pharmaceutical supply chain. As the world strives to emerge from the grip of the pandemic and restore activities reminiscent of pre-pandemic times, uncertainties surrounding supply chain stability persist. The
In 2022, supply chain challenges have been present in the news every day. Whether it is oil, computer chips, drugs, or baby formula, we have been made aware about how fragile our supply chains are and how many companies are hard at work trying to shore up current supply lines, while preparing for a better future with innovative solutions. Within our own industry, supply chain issues and...
I am very excited to be leading the Supply Chain, Operations, and Packaging Excellence (SCOPE) track this year at the 2021 ISPE Annual Meeting & Expo. Just like its name, this track will cover a wide...